prospective randomized placebo

Related by string. * prospectives . PROSPECTIVE . pro spective : Identify prospective partners . • Identify prospective . prospective groom / randomizing . randomizer . Randomized : randomized controlled trial . randomized controlled trials . randomized placebo controlled / placebos . Placebos . Placebo : placebo controlled clinical trials . blind placebo controlled * *

Related by context. Frequent words. (Click for all words.) 74 blind randomized placebo 73 placebo controlled randomized 73 multicenter randomized double 72 Phase III randomized 72 multicenter randomized 70 active comparator 70 double blind placebo 70 randomized Phase III 68 blind randomized 68 multicentre 68 randomized double 68 randomized placebo controlled 67 prospective randomized controlled 67 prospective randomized 67 multicenter 66 Randomized 66 placebo controlled 66 phase IIa 65 phase IIb 65 nab paclitaxel 65 multicenter clinical 64 randomized clinical 64 randomized 64 blind randomized controlled 64 SCH # 64 randomized controlled 64 Phase Ib 63 tocilizumab 63 prospective observational 63 Phase 1b trial 62 dose escalation trial 62 Phase 1b clinical 62 randomized #:# 61 dose escalation 61 placebo controlled studies 61 blinded placebo controlled 61 Phase 1a 61 Phase 2a clinical 61 CA4P 61 Phase 2b study 61 randomized controlled clinical 61 randomized Phase 60 lacosamide 60 Phase IIb clinical 60 dose regimens 60 Phase 2a trial 60 label dose escalation 60 diabetic neuropathic pain 59 dabigatran etexilate 59 dose cohorts 59 multicenter study 59 Phase Ia 59 Phase 2b 59 Phase 2b trial 59 Rosuvastatin 59 ISIS # 59 TELCYTA 59 Phase 2b clinical 59 nitazoxanide 59 randomized trials 59 dose escalation study 59 noninferiority 59 unblinded 59 clinical trial 59 aflibercept 59 Phase IIb 59 Phase 1b 58 Phase IIa clinical 58 imetelstat 58 evaluable patients 58 sunitinib 58 muraglitazar 58 randomisation 58 SRT# [003] 58 phase 2a 58 seliciclib 58 BAY #-# 58 subgroup analyzes 58 placebo controlled trials 58 EORTC 58 Phase IIa 58 serum phosphorus 58 tolerated dose MTD 58 rosuvastatin 58 Phase IIa trial 58 bosentan 58 azacitidine 58 peginterferon alfa 2a 57 randomized clinical trials 57 DSMB 57 secondary efficacy endpoints 57 hypertensive patients 57 Phase IIb trial 57 thymalfasin 57 adalimumab 57 6R BH4 57 confirmatory Phase III 57 axitinib 57 dacarbazine 57 tesmilifene 57 Taxotere ®

Back to home page